Deals
Allergan near buyout of up to $65 billion to escape Valeant, Ackman: source
Allergan Inc is close to a buyout deal worth up to $65.5 billion by Actavis Plc, one that could end months of pursuit by Canada’s Valeant Pharmaceuticals and William Ackman's hedge fund, Pershing Square Capital Management, according to a person familiar with the matter.
Wal-Mart's Vudu joins Disney's cloud movie service
Walt Disney Co's cloud-based movie storage service will give customers the ability to add purchases from Vudu, an online store operated by Wal-Mart Stores Inc, a Disney official said on Friday.
Deal to spur better 911 call locating for U.S. cellphone users
Emergency responders will be able to better locate callers who dial 911 on their cellphones from indoors as the U.S. wireless industry improves caller-location for the majority of such calls over the next six years.
ContraFect Corporation Announces Third Quarter 2014 Results
ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW) (NASDAQ: CFRXZ), a biotechnology company focused on the discovery and development of protein therapeutics and antibody products for life-threatening, drug-resistant infectious diseases, today announced results for the third quarter ended September 30, 2014. The Company closed its initial public offering (IPO) on August 1, 2014.




